Zoledronic Acid for Periprosthetic Bone Mineral Density Changes in Patients With Osteoporosis After Hip Arthroplasty—An Updated Meta-Analysis of Six Randomized Controlled Trials

Introduction: Periprosthetic bone mineral density (BMD) loss following total hip arthroplasty (THA) may threaten the survival of the implant, especially in patients with osteoporosis. Zoledronic acid (ZA) is the representative of the third generation of bisphosphonates, which were effective in reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuan, Xu, Jia-Wen, Li, Ming-Yang, Wu, Li-Min, Zeng, Yi, Shen, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733298/
https://www.ncbi.nlm.nih.gov/pubmed/35004777
http://dx.doi.org/10.3389/fmed.2021.801282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733298/
https://www.ncbi.nlm.nih.gov/pubmed/35004777
http://dx.doi.org/10.3389/fmed.2021.801282

Ejemplares similares